Eccrine squamous syringometaplasia;Siringometaplasia escamosa ecrina

Actas Dermo-Sifiliograficas

Volumn 92, Issue 1-2, 2001, Pages 13-24

  Valks, Ruud ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Chemotherapy; Eccrine gland; Eccrine squamous syringometaplasia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ARTICLE; DERMATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; SKIN BIOPSY; SKIN ULCER; SQUAMOUS CELL METAPLASIA; SWEAT GLAND;

EID: 0035052613     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(01)79135-1     Document Type: Article

References (53)

1. Lobitz WC, Holyoke JB, Montagna W. Responses of the human eccrine sweat duct to controlled injury. J Invest Dermatol 1954;23:329-44.
2. Lobitz WC, Holyoke JB, Brophy D. Response of the human eccrine sweat duct to dermal injury. J Invest Dermatol 1956;26:247-62.
3. Johnson HL, Maibach HI. Drug excretion in human eccrine sweat. J Invest Dermatol 1971;56:182-8.
4. Shah VP, Epstein WL, Riegelman S. Role of sweat in accumulation of orally administered griseofulvin in skin. J Clin Invest 1974;53:1673-8.
5. Parnas J, Flachs H, Gram L, Wurtz-Jorgensin A. Excretion of antiepileptic drugs in sweat. Acta Neurol Scand 1978;58:197-204.
6. Harris R, Jones HE, Artis WM. Orally administered ketoconazole: route of delivery to the human stratum corneum. Antimicrob Agents Chemother 1983;24:876-82.
7. Horn TD, Beveridge RA, Egorin MJ, Abeloff MJ, Hood AF. Observations and proposed mechanism of N,N',N"-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation. Arch Dermatol 1989;125:524-7.
8. Hoiby N, Jarlov JO, Kemp M, Tvede M, Bangsborg JM, Kjerulf A, Pers C, Hansen H. Excretion of ciprofloxacin in sweat and multiresistant staphylococcus epidermis. Lancet 1997;349:167-9.
9. a ed. Nueva York: Interamericana McGraw-Hill; 1995. p. 39-55.
10. Cornil V. Contributions à l'histoire du dévelopment histologique des tumeurs épithéliales. J de L'Anat et Physiol 1865;2:476 (citado por 44).
11. Lever WF. Adenoacanthoma of sweat glands. Arch Derm Syph 1947;56:157-71.
12. a ed. Philadelphia: Lippincott-Raven Publ; 1997. p. 685-746.
13. Freeman RG, Rossman RE. Pathogenesis of keratoacanthoma. Tex State J Med 1963;59:479-83.
14. Freeman RG. On the pathogenesis of pseudoepitheliomatous hyperplasia. J Cutan Pathol 1974;1:231-7.
15. King DT, Barr RJ. Syringometaplasia: mucinous and squamous variants. J Cutan Pathol 1979;6:284-91.
16. Mehregan AH. Proliferation of sweat ducts in certain diseases of the skin. Am J Dermatopathol 1981;3:27-31.
17. Allegue F, Rocamora A, Martín-González M, Alonso ML, Ledo A. Infectious eccrine hidradenitis J Am Acad Dermatol 1990;22:1119-20.
18. Metcalf JS, Maize JC. Squamous syringometaplasia in lobular panniculitis and pyoderma gangrenosum. Am J Dermatopathol 1990;12:141-9.
19. Helton JL, Metcalf JS. Squamous syringometaplasia in association with annular elastolytic granuloma. Am J Dermatopathol 1995;17:407-9.
20. Muñoz E, Valks R, Fernández-Herrera J, Fraga J. Herpetic syringitis associated with eccrine squamous syringometaplasia in HIV-positive patients. J Cutan Pathol 1997;24:425-8.
21. Shulman HM, Sale GE, Lerner KG, Barker EA, Weiden PL, Sullivan K, Gallucci RN, Thomas ED, Storb R. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978;92:545-70.
22. Akosa AB, Lampert IA. The sweat gland in graft versus host disease. J Pathol 1990;161:261-6.
23. Lerner TH, Barr RJ, Dolezal JF, Stagnone JJ. Syringomatous hyperplasia and eccrine squamous syringometaplasia associated with benoxaprofen therapy. Arch Dermatol 1987;123:1202-4.
24. Caputo R, Monti M, Ermacora E, Carminati G, Gelmetti C, Gianotti R, Gianni E, Puccinelli V. Cutanous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents. J Am Acad Dermatol 1988;19:812-9.
25. Cribier B, Lipsker D, Grosshans E. Syringométaplasie kératinisante: manifestation originale d'une pathomimie. Ann Dermatol Venereol 1993;120:900-3.
26. Sommer B, Hagedorn M, Wood F, Heenan P. Eccrine squamous syringometaplasia in the skin of children after burns. J Cutan Pathol 1998;25:56-8.
27. Serrano T, Sáez A, Moreno A. Eccrine squamous syringometaplasia. A prospective clinicopathologic study. J Cutan Pathol 1993;20:61-5.
28. Santa Cruz DJ, Samuels LE, Bauer EA, Phillips GL, Herzig GP. Epidermal dystrophy: clinicopathologic study of chemotherapeutic agent toxicity in ten patients. Lab Invest 1982;46:72.
29. Flynn TC, Harrist TJ, Murphy GF, y cols. Neutrophilic eccrine hidradenitis: a distinctive rash associated with cytarabine therapy and acute leukemia. J Am Acad Dermatol 1984;11:584-90.
30. Scallan PJ, Kettler AH, Levy ML, Tschen JA. Neutrophilic eccrine hidradenitis. Evidence implicating bleomycin as a causative agent. Cancer 1988;62:2532-6.
31. Allegue F, Soria C, Rocamora A, Muñoz E, Freire-Murgueytio P, Arrazola JM, Ledo A. Neutrophilic eccrine hidradenitis in two neutropenic patients. J Am Acad Dermatol 1990;23:1110-3.
32. Jones-Caballero M, Fraga Fernández J, Sánchez Pérez J, Fernández Herrera J, García Díez A. Siringometaplasia escamosa ecrina. Actas Dermosifiliogr 1990;81:825-7.
33. Hurt MA, Halverson RD, Petr FC, Cooper JT, Friedman DJ. Eccrine squamous syringometaplasia. A cutaneous sweat gland reaction in the histologic spectrum of «Chemotherapy-associated eccrine hidradenitis» and «neutrophilic eccrine hidradenitis». Arch Dermatol 1990;126:73-7.
34. Bhawan J, Malhotra R. Syringosquamous metaplasia, a distinctive eruption in patients receiving chemotherapy. Am J Dermatopathol 1990;12:1-6.
35. Rongioletti F, Ballestrero A, Bogliolo F, Rebora A. Necrotizing eccrine squamous syringometaplasia presenting as acral erythema. J Cutan Pathol 1991;18:453-6.
36. Wong P, Bangert JL, Levine N. A papulovesicular eruption in a man receiving chemotherapy for metastatic melanoma. Arch Dermatol 1993;129:232-3,235-6.
37. Ríos-Buceta L, Peñas PF, Dauden-Tello E, Fraga-Fernández J, Domínguez-Arciniega P, García-Díez A. Recall phenomenon with the unusual presence of eccrine squamous syringometaplasia. Br J Dermatol 1995;133:630-2.
38. Valks R, Buezo GF, Dauden E, Fraga J, García-Díez A. Eccrine squamous syringometaplasia in intertriginous areas. Br J Dermatol 1996;134:984-6.
39. Valks R, Fraga J, Porras-Luque J, Figuera A, García-Díez A, Fernández-Herrera J. Chemotherapy-induced eccrine squamous syringometaplasia. A distincitive eruption in patients receiving hematopoietic progenitor cells. Arch Dermatol 1997;133:873-8.
40. Templeton SF, Solomon AR, Swerlick RA. Intradermal bleomycin injections into normal human skin. Arch Dermatol 1994;130:577-83.
41. Bhawan J, Petry J, Rybak ME. Histologic changes induced in skin by extravasation of doxorubicin (adriamycin). J Cutan Pathol 1989;16:158-63.
42. Harrist TJ, Fine JD, Berman RS, Murphy GF, Mihm MC. Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol 1982;118: 263-6.
43. Burg G, Bieber T, Langecker P. Lokalisierte neutrophile ekkrine hidradenitis unter mitoxantron: eine typische zytostatikanebenwirkung. Hautarzt 1988;39:233-6.
44. Bailey DL, Barron D, Lucky AW. Neutrophilic eccrine hidradenitis: a case report and review of the literature. Pediatr Dermatol 1989;6:33-8.
45. Greenbaum BH, Heymann WR, Reid CS, Travis SF, Donaldson MH. Chemotherapy-associated eccrine hidradenitis: neutrophilic eccrine hidradenitis reevaluated: the role of neutrophilic infiltration. Med Pediatr Oncol 1988; 16:351-5.
46. Kuttner BJ, Kurban RS. Neutrophilic eccrine hidradenitis in the absence of an underlying malignancy. Cutis 1988; 41: 403-405.
47. Aractingi S, Mallet V, Pinquer L, Chosidow O, Vignon-Pennamen MD, Degos L, Dubertret L, Dombret H. Neutrophilic dermatoses during granulocytopenia. Arch Dermatol 1995;131:1141-5.
48. Prussick R, Horn TD, Wilson WH, Turner MC. A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1a. J Am Acad Dermatol 1996;35:705-9.
49. Vargas-Díez E, Valks R, Fraga J, Fernández-Herrera J, García-Díez A. Eccrine squamous syringometaplasia in a patient with phytophotodermatosis. Int J Dermatol 1998;37:715-17.
50. Fitzpatrick JE. The cutaneous histopathology of chemotherapeutic reactions. J Cutan pathol 1993;20:1-14.
51. Fitzpatrick JE, Hood AF. Histopathologic reactions to chemotherapeutic agents. Adv Dermatol 1988; 3: 161-182.
52. a ed. Philadelphia: Lippincott-Raven publ; 1997. p. 287-303.
53. Paul C, Giachetti S, Pinquier L, Flaguel B, Dubertret L, Calvo F. Cutaneous effects of granulocyte colony-stimulating factor in healthy volunteers. Arch Dermatol 1998;134:111-2.